Cargando…
SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer
OBJECTIVE: We report the use of SpaceOAR hydrogel spacer in interstitial brachytherapy (ISBT) for a patient with intrapelvic recurrent endometrial cancer (EC). METHODS AND MATERIALS: A 59-year-old female patient was diagnosed with intrapelvic recurrence of EC after a definitive surgery. Despite admi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461745/ https://www.ncbi.nlm.nih.gov/pubmed/36101723 http://dx.doi.org/10.1259/bjrcr.20210220 |
_version_ | 1784787023455846400 |
---|---|
author | Takagawa, Yoshiaki Itami, Jun |
author_facet | Takagawa, Yoshiaki Itami, Jun |
author_sort | Takagawa, Yoshiaki |
collection | PubMed |
description | OBJECTIVE: We report the use of SpaceOAR hydrogel spacer in interstitial brachytherapy (ISBT) for a patient with intrapelvic recurrent endometrial cancer (EC). METHODS AND MATERIALS: A 59-year-old female patient was diagnosed with intrapelvic recurrence of EC after a definitive surgery. Despite administration of adjuvant chemotherapy, the recurrent tumour in the right para-rectal fossa increased in size. Salvage radiotherapy, including external beam radiotherapy followed by ISBT boost, was planned. We planned to inject SpaceOAR between the tumour and rectum to reduce the rectal dose in ISBT; transrectal ultrasound-guided SpaceOAR injection was performed using needle applicator insertion. This was followed by computed tomography-based image-guided brachytherapy. RESULTS: The use of SpaceOAR allowed us to achieved both a higher dose for the clinical target volume and a lower dose for the rectum. Furthermore, no ISBT-related complications or acute toxicities were observed. CONCLUSIONS: The preliminary results suggest that SpaceOAR could be effective in increasing the efficacy of ISBT for intrapelvic recurrent EC, while reducing the associated complications. |
format | Online Article Text |
id | pubmed-9461745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Institute of Radiology. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94617452022-09-12 SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer Takagawa, Yoshiaki Itami, Jun BJR Case Rep Case Report OBJECTIVE: We report the use of SpaceOAR hydrogel spacer in interstitial brachytherapy (ISBT) for a patient with intrapelvic recurrent endometrial cancer (EC). METHODS AND MATERIALS: A 59-year-old female patient was diagnosed with intrapelvic recurrence of EC after a definitive surgery. Despite administration of adjuvant chemotherapy, the recurrent tumour in the right para-rectal fossa increased in size. Salvage radiotherapy, including external beam radiotherapy followed by ISBT boost, was planned. We planned to inject SpaceOAR between the tumour and rectum to reduce the rectal dose in ISBT; transrectal ultrasound-guided SpaceOAR injection was performed using needle applicator insertion. This was followed by computed tomography-based image-guided brachytherapy. RESULTS: The use of SpaceOAR allowed us to achieved both a higher dose for the clinical target volume and a lower dose for the rectum. Furthermore, no ISBT-related complications or acute toxicities were observed. CONCLUSIONS: The preliminary results suggest that SpaceOAR could be effective in increasing the efficacy of ISBT for intrapelvic recurrent EC, while reducing the associated complications. The British Institute of Radiology. 2022-03-09 /pmc/articles/PMC9461745/ /pubmed/36101723 http://dx.doi.org/10.1259/bjrcr.20210220 Text en © 2022 The Authors. Published by the British Institute of Radiology https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Case Report Takagawa, Yoshiaki Itami, Jun SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title | SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title_full | SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title_fullStr | SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title_full_unstemmed | SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title_short | SpaceOAR hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
title_sort | spaceoar hydrogel spacer in interstitial brachytherapy for intrapelvic recurrent endometrial cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461745/ https://www.ncbi.nlm.nih.gov/pubmed/36101723 http://dx.doi.org/10.1259/bjrcr.20210220 |
work_keys_str_mv | AT takagawayoshiaki spaceoarhydrogelspacerininterstitialbrachytherapyforintrapelvicrecurrentendometrialcancer AT itamijun spaceoarhydrogelspacerininterstitialbrachytherapyforintrapelvicrecurrentendometrialcancer |